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Parkinson’s disease is characterized by the accumulation of
neuronal deposits comprising largely the protein R-synuclein
(R-syn).1,2 Although rare heritable forms of the disease have been
documented,3–6 the sporadic form is far more common and possibly
connected to environmental factors that promote oxidative stress
and aberrant metal-mediated redox chemistry.7–12 Indeed, metal-
enhanced oligomerization has been observed for R-syn in vitro,13,14
and there is evidence that specific metal-protein interactions are
critical in neurodegenerative diseases involving other amyloidogenic
polypeptides such as amyloid  peptide (Alzheimer’s disease),15–17
prion protein (spongiform encephalopathies),18,19 and superoxide
dismutase (amyotrophic lateral sclerosis).20,21 A difficult issue to
resolve is whether metal ions perturb protein structures and thereby
alter function, whether metal-protein complexes directly participate
in the production of reactive oxygen species, or whether both
mechanisms are at work.
We have employed tryptophan fluorescence measurements to
probe Cu(II)-protein binding in four mutants containing single W
substitutions (F4W, Y39W, F94W, and Y125W: Figure 1).22 Upon
addition of Cu(II) (0.3-60 µΜ), the tryptophan fluorescence is
quenched site-specifically (Figures 1S and 2S in Supporting
Information). The fluorophore at position 4 is the most strongly
quenched (>80% at [Cu(II)] ) [protein] ) 5 µM, vide infra), while
W39 exhibits minimal quenching until more than 1 equiv of Cu(II)
has been added (∼20% fluorescence decrease at 10 equiv of Cu(II),
Figure 3S in Supporting Information). Even though the participation
of the N-terminal amino group23 and residues in the vicinity of
3-924 have been implicated in Cu(II) binding, our observation was
somewhat unexpected because H50 was identified previously as
the Cu(II) ligand with the strongest affinity.23,24 Furthermore,
neither W94 nor W125 reporter in the highly acidic (15 carboxylate
groups) C-terminal region25 is sensitive to the presence of Cu(II)
under these solution conditions, and fluorescence energy transfer
kinetics measured for W39fY(NO2) pairs near H50 (Y19-W39
and W39-Y55) show no detectable changes upon the addition of
Cu(II). The data confirm that Cu(II) binding to R-syn does not
induce a significant conformational change between residues 19
and 55 (data not shown).
We examined the F4W protein in greater depth to probe binding
in the N-terminal region because W4 is most sensitive to the
presence of Cu(II). In addition, we replaced H50 with a serine
residue (F4W/H50S variant) to assess the role, if any, of imidazole
ligation to Cu(II). Upon copper(II) addition (25 nM to 50 µM
CuSO4 in deoxygenated 20 mM MOPS, 100 mM NaCl pH 7, 25
°C), tryptophan fluorescence is dramatically quenched, owing to
direct Cu(II)-protein interactions (Figure 2).26 Titration curves for
the two proteins (F4W and F4W/H50S) clearly demonstrate that
one copper ion binds per protein, with a dissociation constant of
<5 µM.
To obtain reliable values for Cu-syn dissociation constants, we
measured tryptophan excited-state decay kinetics at submicromolar
protein concentrations ([R-syn] ) 100 nM, Figure 4S in Supporting
Information). The kinetics revealed two fluorescence quenching
modes. Although 1 equiv of Cu(II) reduces steady-state W
fluorescence to ∼10% of its initial value (Figure 2), acceleration
of W4 fluorescence decay (Supporting Information, Figures 5S and
6S) only accounts at most for a∼40% reduction in W4 fluorescence
intensity (Figure 3, top). The remainder of the observed steady-
state quenching must arise from formation of a nonluminescent
ground-state complex between W4 and Cu(II) (static quenching)
or a dynamic process that proceeds on a time scale substantially
shorter than the resolution of our decay measurements (<100 ps).
We can fit the titration curves derived from the average lifetime
data using a single-site binding model (Figure 3, Supporting
Information: F4W, Kd ) 100(50) nM and F4W/H50S, Kd ) 110(50)
nM). The similarity in binding constants for the F4W and F4W/
H50S proteins clearly indicates that the high-affinity site does not
involve the H50 imidazole group,27 an observation that is consistent
with recent NMR measurements on an H50A mutant.23 Difficulties
associated with determining the degree of fluorescence quenching
(Figure 3) lead to greater error in the estimated dissociation constant.
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Figure 1. Primary amino acid sequence of human R-synuclein. Potential
side-chain copper(II) ligands (N-terminus, Lys, His, Asp, Glu, and Met)
are colored. Underlined residues indicate the location of Trp probes.
Figure 2. Intensity of R-synuclein fluorescence as a function of added
Cu(II); [R-syn] ) 5 µM in deoxygenated 20 mM MOPS, 100 mM NaCl,
pH 7 buffer.
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W4 fluorescence quenching by Cu(II) likely involves an electron-
transfer process involving contact between the metal ion and the singlet-
excited indole group. The dual quenching modes observed in W4 R-syn
could arise from two distinct Cu(II)-protein sites with similar binding
affinities: one in which W4 and Cu(II) are within static quenching
distance (contact), and the other where W4 is sufficiently close to Cu(II)
to make contact during the∼3 ns excited-singlet lifetime. Alternatively,
the complex fluorescence quenching behavior may reflect a broad
distribution of W4-Cu(II) distances in a structurally heterogeneous
polypeptide that allows the indole side chain to sample different
conformations. Those structures with short W4-Cu(II) distances would
give rise to static quenching, whereas those with longer distances would
be associated with dynamic processes.
The high-affinity N-terminal Cu(II)-binding site revealed by W4
fluorescence quenching does not involve H50 nor global polypeptide
rearrangements that bring W39, W94, or W125 into proximity. We
suggest that the tight binding involves the R-amino group of M1
(human protein contains a free amino terminus28) and the carboxy-
late group of D2, along with deprotonated amides and carbonyl
groups from the peptide backbone, consistent with previous work
on synthetic N-terminal fragments29,30 and similar to the structurally
characterized Cu(II) site in the octarepeat domain of the prion
protein.31 Indeed, the outer-sphere association of a tryptophan indole
side chain with the Cu(II)-peptide complex would likely produce
static fluorescence quenching analogous to that observed in W4
R-syn. The details of intracellular copper ion homeostasis are not
well understood,32 so it is difficult to assess the importance of
Cu(II)-R-syn binding in the natural function of the protein or the
disease state with which it is associated.
Our experiments demonstrate that tryptophan fluorescence is a
sensitive indicator of copper(II) binding to R-synuclein. Because we
can make measurements at extremely low protein concentrations, we
are able to extract reliable dissociation constants for high-affinity
binding sites. With this approach, we can determine how different
R-syn subpopulations interact with other biomolecules and compounds
that are implicated in Parkinson’s disease.
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Figure 3. Average W4 fluorescence lifetimes and fraction of static
quenching extracted from NNLS fits (Supporting Information) of F4W (b)
and F4W/H50S (O) R-synuclein variants ([protein]) 100 nM) as functions
of added Cu(II) in deoxygenated 20 mM MOPS, 100 mM NaCl, pH 7 buffer.
Fits to a single-site binding model are shown as solid (F4W) and dashed
(F4W/H50S) lines.
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